Development and validation of a Disease Activity index for PSoriatic Arthritis based on 44 joints (DAPSA44)

Psoriatic Arthritis

The likelihood of joint inflammation recurrence in previously affected joints during psoriatic arthritis disease course

Ann Rheum Dis

Berman M, Elkayam O, Capelusnik D

doi: 10.1016/j.ard.2025.08.020

Rheumatoid Arthritis

Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study

Rheumatology (Oxford)

López-Medina C, Gorlier C, Orbai AM, Coates LC, Kiltz U, Leung YY, Palominos P, Cañete JD, Scrivo R, Balanescu A, Dernis E, Meisalu S, Ruyssen-Witrand A, Soubrier M, Aydin SZ, Eder L, Gaydukova I, Lubrano E, Kalyoncu U, Richette P, Husni ME, Smolen JS, de Wit M, Gossec L

doi: 10.1093/rheumatology/keaf002

Autoimmune Disease

Development and Validation of a Disease Severity Index for Patients with Cold Urticaria

J Allergy Clin Immunol Pract

Altunergi T, Pereira MP, Altrichter S, Gutsche A, Ahsan DM, Fox Cand L, Grekowitz E, Bonnekoh H, Weller K, Maurer M, Salameh P, Terhorst-Molawi D

doi: 10.1016/j.jaip.2025.04.047

Rheumatoid Arthritis

Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort

Semin Arthritis Rheum

Llorca J, Ferraz-Amaro I, Castañeda S, Plaza Z, Sánchez-Alonso F, García-Gómez C, González-Juanatey C, González-Gay MÁ, CARMA Project Collaborative Group

doi: 10.1016/j.semarthrit.2025.152833

Psoriatic Arthritis

Relationship of radiographic progression status to low disease activity in patients with psoriatic arthritis receiving secukinumab treatment for two years

Rheumatology (Oxford)

Mease PJ, Coates LC, Gaillez C, Shew A, Bao W, Ritchlin CT

doi: 10.1093/rheumatology/keaf488

Psoriatic Arthritis

Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies

Ther Adv Musculoskelet Dis

Kristensen LE, Tillett W, Nash P, Coates LC, Mease PJ, Ogdie A, Gisondi P, Ink B, Prickett AR, Bajracharya R, Taieb V, Lyris N, Lambert J, Walsh JA

doi: 10.1177/1759720X241288071

Psoriatic Arthritis

The Impact of Early Attainment of Minimal Disease Activity on Radiographic Outcomes: A Real-World Longitudinal Cohort Study in Psoriatic Arthritis

J Rheumatol

Koc GH, Kok MR, Snoeck Henkemans SVJ, Luime JJ, Tchetverikov I, van der Kaap JH, Baudoin P, Kok P, Goekoop-Ruiterman YPM, Vos PAJM, van Oosterhout M, Korswagen LA, Dolhain RJEM, Vis M

doi: 10.3899/jrheum.2024-1162

Rheumatoid Arthritis

Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT

Arthritis Res Ther

Ramien R, Rudi T, Alten R, Krause A, Schneider M, Schaefer M, Strangfeld A, Meissner Y

doi: 10.1186/s13075-024-03449-9

Systemic Lupus Erythematosus

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state

Rheumatology (Oxford)

Nakanishi E, Matsushita M, Minowa K, Tada K, Kawamoto T, Kusaoi M, Amano H, Kon T, Morimoto S, Ikeda K, Suzuki S, Nozawa K, Yang KS, Matsudaira R, Katagiri A, Tsushima H, Urasaki W, Nojiri S, Yamaji K, Tamura N

doi: 10.1093/rheumatology/keaf349

Related content

The likelihood of joint inflammation recurrence in previously affected joints during psoriatic arthritis disease course

Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP study

Development and Validation of a Disease Severity Index for Patients with Cold Urticaria

Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort

Relationship of radiographic progression status to low disease activity in patients with psoriatic arthritis receiving secukinumab treatment for two years

Association of achieving clinical disease control criteria and patient-reported outcomes in bimekizumab-treated patients with active psoriatic arthritis: results from two phase III studies

The Impact of Early Attainment of Minimal Disease Activity on Radiographic Outcomes: A Real-World Longitudinal Cohort Study in Psoriatic Arthritis

Impact of systemic inflammation and disease activity on the incidence of interstitial lung disease in patients with rheumatoid arthritis - a nested case-control study within the German biologics register RABBIT

Systemic lupus erythematosus-disease activity score remission and low disease activity were similarly associated with patient-reported outcomes compared with definition of remission in systemic lupus erythematosus remission and lupus low disease activity state